跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEVOSIMENDAN ZENTIVA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LEVOSIMENDAN ZENTIVA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Approved
STANDARD
LEVOSIMENDAN ZENTIVA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Zentiva K.S.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 19, 2022
Approval ID
64e9156033dac100
Company
Zentiva K.S.
Type
Standard
Approval Details
Approval Id
64e9156033dac100
Drug Cima Aemps Name
LEVOSIMENDAN ZENTIVA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number
87325
Holder Company Name
Zentiva K.S.
Marketing Company Name
Zentiva Spain S.L.
Holder Company Detail Path
/organization/zentiva-k-s
Authorization Date
2022-05-19
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
2,5 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Zentiva K.S.
Company Detail Path
/organization/zentiva-k-s
Company Information
Pharmaceutical Company Name
Zentiva, k.s.
Country Name
Czech Republic
City Name
praha,hlavní město praha,country_cz
Address
U kabelovny 130/22
Active Ingredients
LEVOSIMENDAN
2,5 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 19, 2022
Approval ID
64e9156033dac100
Type
Standard
Back to CIMA-AEMPS Approvals